Evidence map›Paper›PMID 33377026›Full record

ArticleSTAR protocols2020

Protocol for Probing Regulated Lysosomal Activity and Function in Living Cells.

L V Albrecht, N Tejeda-Muñoz, E M De Robertis

Abstract read
In one paragraph

Article in STAR protocols, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. International journal of molecular sciences · 2025
    Article
  7. Article
  8. Guselkumab binding to CD64Frontiers in immunology · 2025
    Article
  9. Article
  10. Peptide-coated DNA nanostructures as a platform for control of lysosomal function in cells.Chemical engineering journal (Lausanne, Switzerland : 1996) · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

L V AlbrechtDepartment of Biological Chemistry, David Geffen School of Medicine, University of California, Los Angeles 90095-1662, USA.
N Tejeda-MuñozDepartment of Biological Chemistry, David Geffen School of Medicine, University of California, Los Angeles 90095-1662, USA.
E M De RobertisDepartment of Biological Chemistry, David Geffen School of Medicine, University of California, Los Angeles 90095-1662, USA.

Funding

Women's CancersP30CA016042 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Samuel Wheeler French · 1985 to 2026
$134.5M
Wnt Signaling and Endosomal Trafficking as Regulators of Cellular Protein DegradationF32GM123622 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ALBRECHT, LAUREN VERONICA · 2017 to 2019
$118k
Howard Hughes Medical InstituteNCI NIH HHS P30 CA016042NIGMS NIH HHS F32 GM123622
6 · The paper itself

Abstract

Lysosomes are the catabolic center of the cell. Limitations of many lysosomal tracers include low specificity and lack of reliable physiological readouts for changes in growth factor-regulated lysosomal activity. The imaging-based protocols described here provide insights at the cellular level to quantify functions essential to lysosomal biology, including β-glucosidase enzymatic cleavage, active Cathepsin D, and pH regulation in real time. These optimized protocols, applied in different cell types and pathophysiologic contexts, provide useful tools to study lysosome function in cultured living cells. For complete details on the use and execution of this protocol, please refer to Albrecht et al. (2020).

Indexed as

Animalsbeta-GlucosidaseCell LineCells, CulturedHomeostasisHumansHydrogen-Ion ConcentrationLysosomesMolecular Imagingbeta-Glucosidase

Identifiers

PMID33377026
PMCPMC7757114

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.